Some physicians and patients have reported temporary relief from primary symptoms of chronic fatigue syndrome (CFS) immediately
after hyperbaric oxygen therapy (HBOT). In one study HBOT has also been shown to relieve general fatigue and to reduce the
pain associated with fibromyalgia and other chronic pain disorders whose symptoms sometimes resemble CFS.
Physicians may prescribe
hyperbaric oxygen as an adjunct or alternative to drug treatments and other therapies, but treatment of CFS with HBOT is not
approved by the UHMS and not reimbursed by most insurance plans.
Although a single study of a small number of patients produced positive results
[ UHM, 2013 ],
there has yet to be a controlled study of treatment of CFS with HBOT and as of July 2015 none are planned.
[ ClinicalTrials.gov ]
Because the placebo effect cannot be excluded when uncontrolled studies produce positive results, we rate the amount of clinical evidence
supporting the treatment of chronic fatigue syndrome with hyperbaric oxygen therapy at none.
Those seeking treatment for chronic fatigue syndrome should beware of practitioners making bold claims for hyperbaric oxygen therapy.
Advertising a specific medical benefit from a treatment that has not been approved by the US Food and Drug Administration for
that purpose is a violation of US federal law. Never pay to participate in a clinical trial.